AMZN vs JNJ: Which Is the Better Buy?
Side-by-side comparison of Amazon.com, Inc. and Johnson & Johnson — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-25.
Amazon.com, Inc. · Consumer Cyclical
$251.19
+18.5% upside to fair value
Med Conviction
Grade B
High Quality
VS
Johnson & Johnson · Healthcare
$270.68
+5.7% upside to fair value
Med Conviction
Grade C
High Quality
QuantHub Verdict
AMZN has more upside to fair value
(+18.5%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
AMZN |
JNJ |
| Current Price |
$251.19 |
$270.68 |
| Fair Value Estimate |
$297.67 |
$286.05 |
| Upside to Fair Value |
+18.5%
|
+5.7%
|
| Market Cap |
$2,702.1B |
$652.3B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
11.2x
|
20.2x
|
| Price / Sales |
3.5x
|
6.7x
|
| Price / FCF |
—
|
35.3x
|
| Revenue Growth YoY |
+19.6%
|
+6.6%
|
| Gross Margin |
50.8%
|
67.9%
|
| Operating Margin |
12.1%
|
26.8%
|
| Return on Equity |
30.5%
|
25.7%
|
| Dividend Yield |
0% |
1.95% |
| FCF Yield |
—
|
2.83%
|
| Analyst Consensus |
Strong Buy
|
Buy
|
Investment Thesis
Amazon.com operates a vast global retail enterprise spanning online and physical stores, third-party seller services, advertising, subscription offerings, and Amazon Web Services, the world's largest cloud infrastructure provider. The business quality is high: trailing-twelve-month gross margin of 50.8%, operating margin of 12.1%, and net margin of 17.4% reflect a durable mix shift toward high-ma…
Johnson & Johnson is a 141,700-employee healthcare holding company operating two segments, Innovative Medicine (immunology, oncology, neuroscience, infectious disease, cardiovascular and metabolism, pulmonary hypertension) and MedTech (interventional solutions, orthopaedics, surgery, vision), founded in 1887 and headquartered in New Brunswick, New Jersey. Business quality is high on fundamentals:…
Accumulation Zones
| Metric |
AMZN |
JNJ |
| Zone Low |
$223.25 |
$214.54 |
| Zone High |
$253.02 |
$243.14 |
| In Buy Zone? |
Yes
|
No
|